Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)
Clinical trial NCT06903871 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06903871
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2029-03-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.